In the News Pyrexar HT Hyperthermia

enfrdehija

Pyrexar receives final authorization to sell Thermal Therapy devices in Korea

Pyrexar’s line of hyperthermia-based cancer treatment products has received approval from the Korea Good Manufacturing Practice (KGMP).  Similar to ISO 13485 quality system standards, KGMP is required by the Korea Ministry of Food and Drug Safety (MFDS) and opens the door for shipment to, and use of, Pyrexar products in South Korea.

The MFDS, formerly known as the KFDA (Korea Food and Drug Administration), is a South Korea government agency responsible for promoting the public health by ensuring the safety and efficiency of foods, pharmaceuticals, medical devices and cosmetics as well as supporting the development of the food and pharmaceutical industries. In addition to their goal to offer people safe foods and drugs that perform as prescribed.

“We are looking forward to participating in the South Korea medical device marketplace,” says Mark Falkowski, CEO Pyrexar Medical.  “Korea ranks 11th in GDP and per capita healthcare expenditures are rising. We believe our products can be put to good work in this country”.

ABOUT PYREXAR MEDICAL:
Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective thermal therapy/hyperthermia treatment systems with established distribution and support networks around the world. PYREXAR HyperThermia (PYREXAR HT) treatments, proven in multiple clinical trials over the last 30 years, increase the effective dose of ionizing radiation in solid tumors up to 3X without increasing toxicity to healthy tissues.
 
To find out more about Pyrexar Medical products, visit our webpage www.pyrexar.com.  For information about purchasing our products in South Korea, contact HanBeamTek.com

News Archive

  • PYREXAR Medical Acquires Hyperthermia Assets of BSD Medical +

    Promising Cancer Treatment Technology Now Under New Leadership Salt Lake Read More
  • Pyrexar Medical closes deal with HanBeam Technology +

    Hyperthermia products find distribution in South Korea Salt Lake City, Read More
  • Pyrexar Chief Scientist Goes to China +

    PYREXAR HT Hyperthermia products find distribution with Orientech SALT LAKE Read More
  • Pyrexar Medical expands Hyperthermia to Central Asia +

    PYREXAR HT Hyperthermia products find distribution with ORB Corporation SALT Read More
  • Pyrexar brings the Fight Against Cancer to South Korea +

    Pyrexar receives final authorization to sell Thermal Therapy devices in Read More
  • 1
  • 2
  • 3

Contact Info

We are pleased to hear from you. If we can help you with Pyrexar HT products, Clinical Studies or the Advancement of Hyperthermia. We would love to hear what you have to say.

Telephone

+1-(844)-797-3927


Address

1825 West Research Way, Ste E
Salt Lake City, UT 84119, USA

Spread the word about Hyperthermia.

facebooktwittergoogleplus
Contact Request
Thank you for contacting Pyrexar Medical.  Please let us know how we can assit you and we will reply at the first opportunity.
Contact Request
Thank you for your interest in the BSD-500 Superficial/Interstitial Hyperthermia System.  Please complete the form to receive your Brochure.
Contact Request
Thank you for your interest in the BSD-2000 Deep Regional Hyperthermia System.  Please complete the form to receive your Brochure.
Contact Request
Thank you for your interest in the BSD-2000 3D Deep Regional Hyperthermia System.  Please complete the form to receive your Brochure.
Contact Request
Thank you for your interest in the BSD-2000 3D/MR Deep Regional Hyperthermia System.  Please complete the form to receive your Brochure.